Cefotetan CAS:69712-56-7
Cefotetan is prescribed by healthcare providers for the treatment of infections such as respiratory tract infections, urinary tract infections, gynecological infections, intra-abdominal infections, skin and soft tissue infections, and pelvic inflammatory disease. It is essential to consult a healthcare professional before using cefotetan to determine the appropriate dosage and duration of treatment based on the specific type and severity of the infection. Cefotetan is typically administered intravenously or intramuscularly under medical supervision to ensure proper delivery and monitoring of therapeutic response. Patients should adhere to the prescribed dosing schedule and complete the full course of treatment as directed, even if symptoms improve before completion. While cefotetan is generally well-tolerated, common side effects may include diarrhea, nausea, vomiting, or allergic reactions. In some cases, more severe adverse effects such as Clostridium difficile-associated diarrhea or hypersensitivity reactions may occur and require immediate medical attention. It is important to report any concerning symptoms to a healthcare provider promptly. Overall, cefotetan is an effective antibiotic option for combating bacterial infections when used appropriately under medical guidance.
Composition | C17H17N7O8S4 |
Assay | 99% |
Appearance | white powder |
CAS No. | 69712-56-7 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |